KR20190038791A - 전신 홍반성 루푸스의 바이오마커 시그니처 및 그 용도 - Google Patents

전신 홍반성 루푸스의 바이오마커 시그니처 및 그 용도 Download PDF

Info

Publication number
KR20190038791A
KR20190038791A KR1020197000245A KR20197000245A KR20190038791A KR 20190038791 A KR20190038791 A KR 20190038791A KR 1020197000245 A KR1020197000245 A KR 1020197000245A KR 20197000245 A KR20197000245 A KR 20197000245A KR 20190038791 A KR20190038791 A KR 20190038791A
Authority
KR
South Korea
Prior art keywords
ser
gly
leu
ala
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020197000245A
Other languages
English (en)
Korean (ko)
Inventor
카를 보레바에크
파얌 델파니
린다 덱슬린 멜비
크리스터 빈그렌
Original Assignee
이뮤노비아 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이뮤노비아 에이비 filed Critical 이뮤노비아 에이비
Publication of KR20190038791A publication Critical patent/KR20190038791A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104—Lupus erythematosus [SLE]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
KR1020197000245A 2016-06-07 2017-06-07 전신 홍반성 루푸스의 바이오마커 시그니처 및 그 용도 Ceased KR20190038791A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1609951.7 2016-06-07
GBGB1609951.7A GB201609951D0 (en) 2016-06-07 2016-06-07 Biomarkers signatures and uses thereof
PCT/EP2017/063855 WO2017211896A1 (en) 2016-06-07 2017-06-07 Biomarker signatures of systemic lupus erythematosus and uses thereof

Publications (1)

Publication Number Publication Date
KR20190038791A true KR20190038791A (ko) 2019-04-09

Family

ID=56508210

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197000245A Ceased KR20190038791A (ko) 2016-06-07 2017-06-07 전신 홍반성 루푸스의 바이오마커 시그니처 및 그 용도

Country Status (12)

Country Link
US (2) US20200041504A1 (enExample)
EP (1) EP3465209A1 (enExample)
JP (1) JP2019526810A (enExample)
KR (1) KR20190038791A (enExample)
CN (1) CN109690312A (enExample)
AU (1) AU2017277583A1 (enExample)
BR (1) BR112018075223A2 (enExample)
CA (1) CA3026574A1 (enExample)
GB (1) GB201609951D0 (enExample)
MX (1) MX2018015140A (enExample)
RU (1) RU2018142846A (enExample)
WO (1) WO2017211896A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201014837D0 (en) 2010-09-07 2010-10-20 Immunovia Ab Biomarker signatures and uses thereof
WO2020081204A1 (en) * 2018-10-18 2020-04-23 Oklahoma Medical Research Foundation Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity
GB201904472D0 (en) * 2019-03-29 2019-05-15 Immunovia Ab Methods, arrays and uses thereof
CN118948243B (zh) * 2024-07-23 2025-10-17 中国医科大学附属第一医院 基于机器学习对神经精神狼疮进行影像组学诊断的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039578B1 (en) 1980-05-02 1985-04-10 Edward P. Davis Leg aid device
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
US20070141627A1 (en) * 2005-10-19 2007-06-21 Behrens Timothy W Systemic Lupus Erythematosus
GB201014837D0 (en) * 2010-09-07 2010-10-20 Immunovia Ab Biomarker signatures and uses thereof
WO2014008426A2 (en) * 2012-07-06 2014-01-09 Ignyta, Inc. Diagnosis of systemic lupus erythematosus
US20160223537A1 (en) * 2013-09-11 2016-08-04 Singapore Health Services Pte Ltd Identification of novel biomarkers of flares of systemic lupus erythematosus
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
GB201410226D0 (en) * 2014-06-09 2014-07-23 Immunovia Ab Methods and arrays for use in the same
CA2997838A1 (en) * 2014-10-07 2016-04-14 University Health Network Urinary biomarkers for sle and lupus nephritis

Also Published As

Publication number Publication date
WO2017211896A9 (en) 2019-03-14
RU2018142846A (ru) 2020-07-09
US20200041504A1 (en) 2020-02-06
JP2019526810A (ja) 2019-09-19
EP3465209A1 (en) 2019-04-10
MX2018015140A (es) 2019-08-16
US20230063017A1 (en) 2023-03-02
GB201609951D0 (en) 2016-07-20
AU2017277583A1 (en) 2019-01-03
WO2017211896A1 (en) 2017-12-14
CN109690312A (zh) 2019-04-26
AU2017277583A9 (en) 2019-08-01
CA3026574A1 (en) 2017-12-14
BR112018075223A2 (pt) 2019-03-19
RU2018142846A3 (enExample) 2020-09-16

Similar Documents

Publication Publication Date Title
Cavazzana et al. Systemic sclerosis-specific antibodies: novel and classical biomarkers
US20220214344A1 (en) Method, array and use thereof
US20230063017A1 (en) Biomarker signatures of systemic lupus erythematosus and uses thereof
US10859572B2 (en) Biomarker signatures and uses thereof
Hardt et al. Integrated single cell and spatial transcriptomics reveal autoreactive differentiated B cells in joints of early rheumatoid arthritis
WO2008064336A9 (en) Autoimmune disease biomarkers
US20230074480A1 (en) Biomarker signatures of systemic lupus erythematosus and uses thereof
ES3005230T3 (en) Diagnostic and therapeutic methods for the treatment of rheumatoid arthritis (ra)
WO2020104705A9 (en) Predicting a treatment response in inflammatory bowel disease
Gong et al. Plasma sMer, sAxl and GAS6 levels correlate with disease activity and severity in lupus nephritis
WO2017175228A1 (en) Infiltrating immune cell proportions predict anti-tnf response in colon biopsies
WO2020081204A1 (en) Biomarkers for a systemic lupus erythematosus (sle) disease activity immune index that characterizes disease activity
US20120077689A1 (en) Compartment-Specific Non-HLA Targets for Diagnosis and Prediction of Graft Outcome
EP3283889B1 (en) Method and assay for diagnosing rapidly progressive glomerulonephritis in a subject
Keppeke et al. Future Direction of Laboratory Testing for Autoimmune Diseases
EP2297580B1 (en) Antibody against Ephrin Type-A receptor 7 for treatment of bladder cancer
US20220163524A1 (en) Methods, arrays and uses thereof for diagnosing or detecting an autoimmune disease
Chen et al. Anti-peptide antibodies, anti-SNRK and anti-HUWE1 antibodies as potential predictors of good response to tofacitinib therapy in rheumatoid arthritis patients
US20200190589A1 (en) Use of markers in the diagnosis and treatment of lupus
Leon et al. Fatigue in Sjögren’s syndrome: a search for
Singh et al. IRACON 2017
Goonetilleke Proteomics of cerebrospinal fluid in patients diagnosed with pneumococcal meningitis

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20190104

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200605

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210823

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20211101

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20210823

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I